Benzinga | May 13, 2021 04:15PM EDT

Biolase Q1 EPS $(0.06) Misses $(0.05) Estimate, Adj. EBITDA Loss $5.3M vs Loss $3.6M In Same Qtr. Last Year, Sales $8.12M Beat $7.79M Estimate

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 68.42 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $8.12 million which beat the analyst consensus estimate of $7.79 million by 4.18 percent. This is a 69.68 percent increase over sales of $4.78 million the same period last year.